McKinsey & Co // Telehealth: A quarter-trillion dollar post-COVID-19 reality?

By Oleg Bestsennyy, Greg Gilbert, Alex Harris, and Jennifer Rost

Telehealth has helped expand access to care at a time when the pandemic has severely restricted patients’ ability to see their doctors. Actions taken by healthcare leaders today will determine if the full potential of telehealth is realized after the crisis has passed.

COVID-19 has caused a massive acceleration in the use of telehealth. Consumer adoption has skyrocketed, from 11 percent of US consumers using telehealth in 2019 to 46 percent of consumers now using telehealth to replace cancelled healthcare visits.1 Providers have rapidly scaled offerings and are seeing 50 to 175 times2 3 4 the number of patients via telehealth than they did before. Pre-COVID-19, the total annual revenues of US telehealth players were an estimated $3 billion, with the largest vendors focused in the “virtual urgent care” segment: helping consumers get on-demand instant telehealth visits with physicians (m...

To continue reading this post please login or subscribe to Hippo Hive.